Guy J. Dewil, M.D. brings significant life sciences and clinical trial leadership experience across operations, business development and product management
Catalent will continue to manufacture BMS products while offering access to sterile biologics fill/finish and oral solids manufacturing and packaging platforms
Paragon Gene Therapy, part of Catalent Biologics, will provide materials for preclinical and Phase 1/2 trials for IVERIC’s gene therapy product candidates
John Mosack head GMP mfg. at Baltimore site; Adam Sachs to lead program mgmt. and client alliance; Deborah Wild is chief quality and reg. affairs officer
Michael Felo, Director, Downstream Process Integration, Next Generation Processing, MilliporeSigma shares his insight with Contract Pharma at Interphex 2019